The recent overruling of the FDA decision to sell Plan B over the counter (OTC) to children as young as eleven years of age has engendered no small amount of outrage by proponents of the FDA plan, and HHS Secretary Kathleen Sebelius has come in for severe criticism from women’s health and advocacy groups. Setting [...]
Posts Tagged ‘FDA’
Sebelius’ Sensible Decision
Posted in Abortion, Birth Control, Dignity, tagged Family Health International, FDA, NPR, Plan B, Sebelius on December 9, 2011 | 4 Comments »
Ella: Untangling the Ball of Lies (Part II)
Posted in Abortion, tagged AAPLOG, Abortion, Contraception, Ella, ellaOne, FDA on September 14, 2010 | 3 Comments »
My article in today’s HeadlineBistro. The first part of this series showed how the Food and Drug Administration’s (FDA) newest contraceptive drug, Ella (Ulipristal acetate), is in reality an abortifacient like RU-486. It argued that FDA’s marketing of Ella as strictly a contraceptive that denies its abortifacient capabilities, which are abundantly evident to most informed [...]
Ella: Untangling the Ball of Lies (Part 1)
Posted in Abortion, tagged Abortion, Ella, ellaOne, FDA, Miscarriage, RU-486, Ulipristal acetate on August 27, 2010 | 7 Comments »
My Column in today’s Headline Bistro. The FDA’s recent approval of Ella (Ulipristal acetate) as an emergency contraceptive is an action so fraught with lies and incomplete research, that it beggars the imagination. It is a tissue of lies built upon a foundation of lies. Let’s begin with the foundational lies and work our way [...]
ellaOne, More lethal than Plan B, and RU 486 On the Way to US?
Posted in Abortion, Birth Control, tagged ellaOne, FDA, Ulipristal on May 31, 2010 | 4 Comments »
ellaOne (Ulipristal 30 mg) is the new and improved version of RU 486. Its mechanism of action is similar in that it blocks the hormone progesterone from its effect of maintaining the endometrial lining of the uterus. Recall that while estrogen is key to stimulating the growth and development of a new uterine lining (endometrium), [...]
